People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Hospitals and Physicians, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advantia Holdings LLC | — | Hospitals and Physicians | Series C | $212.1M | $33.6M | 2016 |
| Terns Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $97.7M | $2.9B | 2020 |
| vTv Therapeutics Inc. | — | Pharmaceuticals | Series C | $80.5M | $502.3M | 2017 |
Jeffrey Kindler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Kindler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Meister | 1 | 12 |
| Steven Cohen | 1 | 6 |
| Richard Foster | 1 | 6 |
| Craig Parker | 1 | 5 |
| Sean Glass | 1 | 4 |
| John Fry | 1 | 4 |
| Howard Weiner | 1 | 3 |
| Jay A. Martus | 1 | 2 |
| Noel Spiegel | 1 | 2 |
| David Fellows | 1 | 2 |
| Marc Solomon | 1 | 2 |
| Paul J. Sekhri | 1 | 2 |
| Mary Langowski | 1 | 2 |
| Ian Koons | 1 | 2 |
| Leslie Henshaw | 1 | 2 |
| Richard L Nelson | 1 | 2 |
| Paul Savas | 1 | 2 |
| Carl Gordon, Ph.D. | 1 | 2 |
| Rudy Howard | 1 | 2 |
| Elise Wang | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.